聖濟堂(600227.SH):上半年扭虧為盈 淨利1480.69萬元
格隆匯8月20日丨聖濟堂(600227.SH)披露2020年半年度報告,報告期內,公司實現營業收入7.60億元,同比減少18.97%;歸屬於上市公司股東的淨利潤1480.69萬元,而上年同期為虧損2165.76萬元;基本每股收益0.0087元。
報告期內,桐梓化工實現營業收入6.36億元,同比減少10,270.32萬元,同比下降13.9%。營業收入減少的主要原因是主要產品尿素、甲醇的銷售價格較2019年同期相比分別下降了10.64%和25.95%;桐梓化工實現利潤總額444.55萬元,實現扭虧為盈。
報告期內,聖濟堂製藥共生產藥品1836萬盒,比去年同期增加27.50%。其中:西藥1706萬盒(支),比去年同期增加29.24%,中藥131萬盒(瓶),比去年同期增加10.08%,保健品因遷址原因未生產,醫療器械已停止生產。銷售藥品1701萬盒,比去年同期增加17.80%,實現營業收入1.16億元,比去年同期減少38.66%。其中:西藥1601萬盒(支),比去年同期增加30.91%,實現營業收入1.05億元,比去年同期減少32.54%,中藥100萬盒(瓶),比去年同期減少51.92%,實現營業收入1166萬元,比去年同期減少59.95%,實現淨利潤703萬元,比去年同減少85.41%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.